These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27239270)

  • 1. Double blinding requirement for validity claims in cognitive-behavioral therapy intervention trials for major depressive disorder. Analysis of Hollon S,  et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
    Berger D
    F1000Res; 2015; 4():639. PubMed ID: 27239270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder.
    Berger D
    F1000Res; 2015; 4():638. PubMed ID: 26870318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164.
    Hollon SD; DeRubeis RJ; Fawcett J; Amsterdam JD; Shelton RC; Zajecka J; Young PR; Gallop R
    JAMA Psychiatry; 2016 Jun; 73(6):639-40. PubMed ID: 27097060
    [No Abstract]   [Full Text] [Related]  

  • 5. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.
    Guidi J; Tomba E; Fava GA
    Am J Psychiatry; 2016 Feb; 173(2):128-37. PubMed ID: 26481173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential efficacy of cognitive behavioral therapy and psychodynamic therapy for major depression: a study of prescriptive factors.
    Driessen E; Smits N; Dekker JJ; Peen J; Don FJ; Kool S; Westra D; Hendriksen M; Cuijpers P; Van HL
    Psychol Med; 2016 Mar; 46(4):731-44. PubMed ID: 26750445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and Prevention of Depression.
    Hollon SD; Thase ME; Markowitz JC
    Psychol Sci Public Interest; 2002 Nov; 3(2):39-77. PubMed ID: 26151569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.
    Watanabe N; Horikoshi M; Yamada M; Shimodera S; Akechi T; Miki K; Inagaki M; Yonemoto N; Imai H; Tajika A; Ogawa Y; Takeshima N; Hayasaka Y; Furukawa TA;
    Trials; 2015 Jul; 16():293. PubMed ID: 26149441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
    Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
    Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study.
    Parker G; Blanch B; Paterson A; Hadzi-Pavlovic D; Sheppard E; Manicavasagar V; Synnott H; Graham RK; Friend P; Gilfillan D; Perich T
    Acta Psychiatr Scand; 2013 Oct; 128(4):271-81. PubMed ID: 23240706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative management to achieve treatment guidelines. Impact on depression in primary care.
    Katon W; Von Korff M; Lin E; Walker E; Simon GE; Bush T; Robinson P; Russo J
    JAMA; 1995 Apr; 273(13):1026-31. PubMed ID: 7897786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis.
    Boschloo L; Bekhuis E; Weitz ES; Reijnders M; DeRubeis RJ; Dimidjian S; Dunner DL; Dunlop BW; Hegerl U; Hollon SD; Jarrett RB; Kennedy SH; Miranda J; Mohr DC; Simons AD; Parker G; Petrak F; Herpertz S; Quilty LC; John Rush A; Segal ZV; Vittengl JR; Schoevers RA; Cuijpers P
    World Psychiatry; 2019 Jun; 18(2):183-191. PubMed ID: 31059603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.